Data / Drug companies / Pioglitazone
Pioglitazone: 17 companies and 47 products in the FDA NDC directory
Pioglitazone is listed in the FDA National Drug Code Directory by 17 companies, with 47 products in commercial distribution. 44 of the products (93.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on August 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 47
- Generic (ANDA) products
- 44 (93.6%)
- Application numbers
- 5
- Routes
- Oral
- Brand names
- Actos
- openFDA record search
- api.fda.gov
Companies that list pioglitazone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 6 | tablet | Generic drugs (ANDA) | February 4, 2015 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | August 18, 2022 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | February 4, 2015 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | September 17, 2024 |
| Macleods Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | February 14, 2013 |
| NorthStar Rx LLC | 3 | tablet | Generic drugs (ANDA) | August 18, 2022 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | August 27, 2026 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | February 13, 2013 |
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | May 20, 2018 |
| Takeda Pharmaceuticals America, Inc. | 3 | tablet | New drug applications (NDA) | July 15, 1999 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | May 22, 2015 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | January 1, 2026 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | February 13, 2013 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | March 2, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | February 13, 2013 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | June 12, 2020 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | February 13, 2013 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 47 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 44 | 93.6% |
| New drug applications (NDA) | 3 | 6.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Peroxisome Proliferator Receptor alpha Agonist | 47 |
| Peroxisome Proliferator Receptor gamma Agonist | 47 |
| Thiazolidinedione | 47 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.